Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer

por Rudin, C.M., Cervantes, A., Dowlati, A., Besse, B., Ma, B., Costa, D.B., Schmid, P., Heist, R., Villaflor, V.M., Spahn, J., Li, S., Cha, E., Riely, G.J., Gettinger, S.
Publicado 2023

A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours

por Bowles, D W, Ma, W W, Senzer, N, Brahmer, J R, Adjei, A A, Davies, M, Lazar, A J, Vo, A, Peterson, S, Walker, L, Hausman, D, Rudin, C M, Jimeno, A
Publicado 2013

COVID-19 in patients with lung cancer

por Luo, J., Rizvi, H., Preeshagul, I.R., Egger, J.V., Hoyos, D., Bandlamudi, C., McCarthy, C.G., Falcon, C.J., Schoenfeld, A.J., Arbour, K.C., Chaft, J.E., Daly, R.M., Drilon, A., Eng, J., Iqbal, A., Lai, W.V., Li, B.T., Lito, P., Namakydoust, A., Ng, K., Offin, M., Paik, P.K., Riely, G.J., Rudin, C.M., Yu, H.A., Zauderer, M.G., Donoghue, M.T.A., Łuksza, M., Greenbaum, B.D., Kris, M.G., Hellmann, M.D.
Publicado 2020